Company / Shares Outstanding
Cullinan Therapeutics, Inc. Shares Outstanding History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
58.5M
FY2024
5-year range
19.9M / 58.5M
FY2020-FY2024
Trend
+40.8%
vs FY2023
Sector context
#148 of 212
Health Care
What the data says
At 58510610.00, Cullinan Therapeutics, Inc.'s shares outstanding ranks #65 of 212 in the Health Care sector. Increased from 45796449.00 to 58510610.00 over the past 2 years.
Based on SEC 10-K filings.
58510610.00 in FY2024 with a 3-year CAGR of +25.2%.
Increased from 45796449.00 to 58510610.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +25.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#65 of 212 in Health CareTop 30% of 212This company 58.5M Sector average 306.3M
▼
-80.9% below sector average
Key checks
Key Insights
- In FY2024, shares outstanding increased 40.8% year-over-year.
- Ranks #148 out of 212 companies in the Health Care sector.
- Lowest shares outstanding in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 7.33 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | 58.5M | +40.8% |
| FY2023 | 41.5M | -9.3% |
| FY2022 | 45.8M | +53.5% |
| FY2021 | 29.8M | +50.0% |
| FY2020 | 19.9M | - |
As of FY2024 · SEC 10-K · Updated Jul 2, 2026